Chemotherapy once meant:

  • An extended series of visits to a treatment center,
  • Where the patient would be hooked up to an IV, often for hours, and infused with a heavy dose of anticancer drugs and supportive care medicines,
  • All while being constantly monitored by healthcare professionals.

Nowadays, that same process often can be accomplished by simply sending the patient home with a bottle of pills. Read More Here.

Read More

Although oral chemotherapy has dramatically changed the face of cancer treatment, how the drugs are dispensed can be nearly as important as the drugs themselves.

“It’s one thing to prescribe an oral medicine for a patient,” said Guri K. Doshi, MD, a urinary and prostate cancer specialist with Texas Oncology, the state’s largest cancer care provider. “It’s another to get it into their hands.” Read more here.

Read More
image-title

Mission Statement:

HOPE. STRENGTH. LOVE. – Our commitment to patients

Arizona Oncology (AO) is the largest group of medical professionals in Arizona devoted exclusively to cancer care. With over 60 practicing physicians, we serve patients at over 25 locations throughout Arizona, including Arrowhead, Chandler, Cottonwood, Deer Valley, Flagstaff, Glendale, Green Valley, Nogales, Phoenix, Prescott Valley, Rita Ranch, Safford, Scottsdale and Sedona.

Our practice provides comprehensive, compassionate, cancer care in a patient-focused, cost-effective, community-based setting. Care is delivered by a team of medical oncologists, radiation oncologists, gynecologist oncologist, hematologists, transplant specialists, and clinical staff, affiliated with The US Oncology Network, a national oncology network. This large network also gives patients access to nationwide research and clinical trials of promising new drugs in the war against cancer.

Arizona Oncology provides patients with access to the latest treatments, state-of-the-art technology, and an extensive research program. We believe it is beneficial that these therapies are provided in a community setting, close to a patient’s home and support system. Arizona Oncology physicians are supported by talented clinical staff who are sensitive to the needs of cancer patients and their caregivers.

VISION:

To establish a network of comprehensive, fully integrated cancer centers that deliver advanced clinical service while being fully responsive to the ever-changing healthcare environment and to be the leader in the delivery of compassionate, personalized, state-of-the-art oncology care in Arizona, providing our patients access to the latest in technology therapies and techniques.

Continue reading Arizona Oncology

Read More

Written by: Kirollos S. Hanna, PharmD, BCPS, BCOP
Download Here

Patients receiving cancer therapies should be adequately assessed and managed to prevent chemotherapy-induced nausea and vomiting (CINV). 5-hydroxytryptamine (5-HT3) receptor antagonists, neurokinin-1 receptor (NK1R) antagonists, glucocorticoids, benzodiazepines, dopaminergic agents and other therapeutic classes have demonstrated substantial antiemetic activity. Despite proven efficacy, choice of therapy should be tailored to the individual patient based on the distinct types of CINV, patient risk factors and emetogenic potential of therapy. Guidelines for antiemetic therapy for intravenously administered chemotherapy according to the estimated risk of CINV are available from American Society of Clinical Oncology, National Comprehensive Cancer Network and the Multinational Association of Supportive Care in Cancer/ European Society for Medical Oncology1-3. Optimal control and prevention of CINV has been associated with improved adherence to cancer therapy stressing the importance of understanding and adhering to these guidelines4,5.
Continue reading Chemotherapy-Induced Nausea and Vomiting

Read More

Written by: Natasha Heimbigner, PharmD
Download Here

The use of immunotherapy in cancer treatment has been expanding over the last several years. The most common adverse effect with these medications are dermatologic toxicities, gastrointestinal, hepatic, and endocrine toxicities. Management of immunotherapy related rash is an important intervention for the patient’s quality of life and buy in to continuation of therapy. Continue reading Managing Immunotherapy Treatment Related Rash

Read More